Maintenance: On Thursday, June 28 2018, 18:00-18:15, maintenance work on the ZORA servers is scheduled. ZORA will not be available during this period. Thank you for your patience.
Kerr, K M; et al; Bubendorf, L; Stahel, R A (2018). Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project. Annals of Oncology, 29(1):200-208.
Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.
Kerr, K M; Bubendorf, L; Edelman, M J; Marchetti, A; Mok, T; Novello, S; O'Byrne, K; Stahel, R; Peters, S; Felip, E (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9):1681-1690.
Moch, H; Blank, P R; Dietel, M; Elmberger, G; Kerr, K M; Palacios, J; Penault-Llorca, F; Rossi, G; Szucs, T D (2012). Personalized cancer medicine and the future of pathology. Virchows Archiv, 460(1):3-8.
Pirker, R; Herth, F J F; Kerr, K M; Filipits, M; Taron, M; Gandara, D; Hirsch, F R; Grunenwald, D; Popper, H; Smit, E; Dietel, M; Marchetti, A; Manegold, C; Schirmacher, P; Thomas, M; Rosell, R; Cappuzzo, F; Stahel, R (2010). Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. Journal of Thoracic Oncology, 5(10):1706-1713.